BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6653061)

  • 21. CONGENITAL NON SPHEROCYTIC HAEMOLYTIC ANAEMIA DUE TO PYRUVATE-KINASE DEFICIENCY.
    BRUNETTI P; PUXEDDU A; NENCI G; MIGLIORINI E
    Acta Haematol; 1963 Aug; 30():88-102. PubMed ID: 14064793
    [No Abstract]   [Full Text] [Related]  

  • 22. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic anemia due to pyruvate kinase deficiency: characterization of the enzymatic activity from eight patients.
    Black JA; Rittenberg MB; Bigley RH; Koler RD
    Am J Hum Genet; 1979 May; 31(3):300-10. PubMed ID: 463878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-6-PD Guadalajara. A new mutant associated with chronic nonspherocytic hemolytic anemia.
    Vaca G; Ibarra B; Romero F; Olivares N; Cantú JM; Beutler E
    Hum Genet; 1982; 61(2):175-6. PubMed ID: 7129446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency in a Costa Rican family carrying hemoglobin C disease].
    Chaves M; Vives-Corrons JL; Sáenz GF; Pujades MA; Briceño J; Colomer D
    Sangre (Barc); 1990 Apr; 35(2):128-33. PubMed ID: 2363093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.
    Nakashima K; Miwa S; Fujii H; Shinohara K; Yamauchi K; Tsuji Y; Yanai M
    J Lab Clin Med; 1977 Dec; 90(6):1012-20. PubMed ID: 925478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitance of an active and an inactive mutant of red cell pyruvate kinase (PK).
    Zanella A; Rebulla P; Izzo C; Zanuso F; Sirchia G
    Scand J Haematol; 1979 Feb; 22(2):145-53. PubMed ID: 432551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new glucose-6-phosphate dehydrogenase variant (G6PD Iwate) associated with congenital non-spherocytic hemolytic anemia.
    Kanno H; Takano T; Fujii H; Tani K; Morisaki T; Hirono A; Kumakawa T; Ogura H; Takahashi K; Tsutsumi H
    Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):715-9. PubMed ID: 3201886
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyruvate kinase "Göttingen 1,2": congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity.
    Schröter W; Lakomek M; Scharnetzky M; Tillmann W; Winkler H
    Hum Genet; 1982; 60(4):381-6. PubMed ID: 7106777
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital non-spherocytic haemolytic anaemia variants with primary and secondary pyruvate kinase deficiency. I. Erythrokinetic patterns.
    Wazewska-Czyzewska M; Gumińska M
    Br J Haematol; 1979 Jan; 41(1):115-24. PubMed ID: 154342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte pyruvate kinase deficiency: 11 new cases.
    Zanella A; Colombo MB; Miniero R; Perroni L; Meloni T; Sirchia G
    Br J Haematol; 1988 Jul; 69(3):399-404. PubMed ID: 3408673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of erythrocyte pyruvate kinase deficiency and related metabolic disorders in patients with hematological diseases.
    Gherardi M; Bierme R; Corberand J; Vergnes H
    Clin Chim Acta; 1977 Aug; 78(3):465-71. PubMed ID: 18306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression.
    Staal GE; Rijksen G; Vlug AM; Vromen-van den Bos B; Akkerman JW; Gorter G; Dierick J; Petermans M
    Clin Chim Acta; 1982 Feb; 118(2-3):241-53. PubMed ID: 7055983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physico-chemical and kinetic properties of pyruvate kinase in erythrocytes in enzymopathic hemolytic anemia].
    Rotrekl B; Wiedermann B; Mlcochová E; Prokopová M
    Vnitr Lek; 1984 Jun; 30(6):542-9. PubMed ID: 6474860
    [No Abstract]   [Full Text] [Related]  

  • 36. Low substrate affinity of pyruvate kinase variant (PK Sapporo) caused by a single amino acid substitution (426 Arg-->Gln) associated with hereditary hemolytic anemia.
    Kanno H; Fujii H; Miwa S
    Blood; 1993 May; 81(9):2439-41. PubMed ID: 8481523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemolytic anaemia in Basenji dogs. 2. Partial deficiency of erythrocyte pyruvate kinase (PK; EC 2.7.1.40) in heterozygous carriers.
    Andresen E
    Anim Blood Groups Biochem Genet; 1977; 8(3):149-56. PubMed ID: 603097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine-triphosphatase deficiency in a family with non-spherocytic haemolytic anaemia.
    Hanel HK; Cohn J; Harvald B
    Hum Hered; 1971; 21(4):313-9. PubMed ID: 4257922
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyruvate kinase (PK) deficiency in Jordan.
    Karadsheh NS
    Haematologica; 1993; 78(2):80-3. PubMed ID: 8349196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirteen cases of pyruvate kinase deficiency found in Japan.
    Ishida Y; Miwa S; Fujii H; Fujinami N; Takegawa S; Yamato K
    Am J Hematol; 1981; 10(3):239-50. PubMed ID: 7246534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.